Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Current Taxes (2023 - 2025)

Vivos Therapeutics has reported Current Taxes over the past 3 years, most recently at $799000.0 for Q4 2025.

  • Quarterly Current Taxes rose 66.11% to $799000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $799000.0 through Dec 2025, up 66.11% year-over-year, with the annual reading at $799000.0 for FY2025, 66.11% up from the prior year.
  • Current Taxes was $799000.0 for Q4 2025 at Vivos Therapeutics, up from $727000.0 in the prior quarter.
  • Over five years, Current Taxes peaked at $799000.0 in Q4 2025 and troughed at $327000.0 in Q4 2023.
  • The 3-year median for Current Taxes is $582000.0 (2025), against an average of $583000.0.
  • Year-over-year, Current Taxes surged 47.09% in 2024 and then surged 66.11% in 2025.
  • A 3-year view of Current Taxes shows it stood at $327000.0 in 2023, then surged by 47.09% to $481000.0 in 2024, then surged by 66.11% to $799000.0 in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Current Taxes are $799000.0 (Q4 2025), $727000.0 (Q3 2025), and $631000.0 (Q2 2025).